Pegloticase - krystexxa
Ended Awarded Last action
- Contract number
- 36C25922F0369
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,559
Award facts
- Contract value 100% obligated
- $16,558.72 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
About this award
Horizon Therapeutics USA Inc. was awarded a $16,558.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The firm fixed price order is for the purchase of the drug PEGLOTICASE (KRYSTEXXA) to be delivered to a location in Riverwoods, Illinois by June 22, 2022. The contract was awarded on June 17, 2022 and utilizes Master GSA Schedule FSS-61-IB, which provides pharmaceutical products and drugs to government agencies, with no set-aside designation applied. The delivery order will support the VA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network 19.
Quick answers
Who was awarded contract 36C25922F0369?
36C25922F0369 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on June 17, 2022.
How much is contract 36C25922F0369 worth?
The government has obligated $16,559 on 36C25922F0369.
Is contract 36C25922F0369 an order under another contract?
Yes. 36C25922F0369 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25922F0369 competed?
The extent of competition for 36C25922F0369 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award